Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults
Clinical trial NCT00357669 · COMPLETED
Trial details
- NCT number
- NCT00357669
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2007-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.